Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Emerg Infect Dis ; 21(10): 1794-9, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26402378

RESUMO

An Ehrlichia muris-like (EML) pathogen was detected among 4 patients in Minnesota and Wisconsin during 2009. We characterized additional cases clinically and epidemiologically. During 2004-2013, blood samples from 75,077 patients from all 50 United States were tested by PCR from the groEL gene for Ehrlichia spp. and Anaplasma phagocytophilum. During 2007-2013, samples from 69 (0.1%) patients were positive for the EML pathogen; patients were from 5 states: Indiana (1), Michigan (1), Minnesota (33), North Dakota (3), and Wisconsin (31). Most (64%) patients were male; median age was 63 (range 15-94) years; and all 69 patients reported likely tick exposure in Minnesota or Wisconsin. Fever, malaise, thrombocytopenia, and lymphopenia were the most common symptoms. Sixteen (23%) patients were hospitalized (median 4 days); all recovered, and 96% received doxycycline. Infection with the EML pathogen should be considered for persons reporting tick exposure in Minnesota or Wisconsin.


Assuntos
Anaplasma phagocytophilum/patogenicidade , Anaplasmataceae/patogenicidade , Testes Sorológicos/métodos , Carrapatos/parasitologia , Zoonoses/epidemiologia , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anaplasma phagocytophilum/genética , Anaplasmataceae/genética , Animais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Minnesota/epidemiologia , Wisconsin/epidemiologia , Zoonoses/transmissão , Zoonoses/virologia
2.
N Engl J Med ; 365(5): 422-9, 2011 Aug 04.
Artigo em Inglês | MEDLINE | ID: mdl-21812671

RESUMO

BACKGROUND: Ehrlichiosis is a clinically important, emerging zoonosis. Only Ehrlichia chaffeensis and E. ewingii have been thought to cause ehrlichiosis in humans in the United States. Patients with suspected ehrlichiosis routinely undergo testing to ensure proper diagnosis and to ascertain the cause. METHODS: We used molecular methods, culturing, and serologic testing to diagnose and ascertain the cause of cases of ehrlichiosis. RESULTS: On testing, four cases of ehrlichiosis in Minnesota or Wisconsin were found not to be from E. chaffeensis or E. ewingii and instead to be caused by a newly discovered ehrlichia species. All patients had fever, malaise, headache, and lymphopenia; three had thrombocytopenia; and two had elevated liver-enzyme levels. All recovered after receiving doxycycline treatment. At least 17 of 697 Ixodes scapularis ticks collected in Minnesota or Wisconsin were positive for the same ehrlichia species on polymerase-chain-reaction testing. Genetic analyses revealed that this new ehrlichia species is closely related to E. muris. CONCLUSIONS: We report a new ehrlichia species in Minnesota and Wisconsin and provide supportive clinical, epidemiologic, culture, DNA-sequence, and vector data. Physicians need to be aware of this newly discovered close relative of E. muris to ensure appropriate testing, treatment, and regional surveillance. (Funded by the National Institutes of Health and the Centers for Disease Control and Prevention.).


Assuntos
Ehrlichia/classificação , Ehrlichiose/microbiologia , Ixodes/microbiologia , Zoonoses/microbiologia , Animais , Ehrlichia/genética , Ehrlichia/isolamento & purificação , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Minnesota , Filogenia , Reação em Cadeia da Polimerase , Wisconsin , Adulto Jovem
3.
Case Rep Infect Dis ; 2017: 5892846, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28928998

RESUMO

Campylobacter fetus is a zoonotic pathogen that occasionally causes serious, relapsing, invasive disease, especially in immunocompromised hosts. We report a case of relapsing C. fetus diarrheal illness in a 75-year-old woman which resulted in secondary bacteremia and seeding of the left knee prosthetic joint. Patient responded favorably to debridement and retention of prosthesis in addition to six weeks of meropenem followed by chronic oral doxycycline suppressive therapy.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA